A carregar...
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab
BACKGROUND: Bevacizumab is a humanized antibody against vascular endothelial growth factor approved for treatment of recurrent glioblastoma. There is a need to discover imaging biomarkers that can aid in the selection of patients who will likely derive the most survival benefit from bevacizumab. MET...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693191/ https://ncbi.nlm.nih.gov/pubmed/27257279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now086 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|